Polyphor stays above water after Sfr165m IPO
Swiss biopharmaceutical company Polyphor has bucked the trend of recent European IPOs by pricing its IPO at Sfr38, in the top half of the initial Sfr30 to Sfr40 range, and increasing the size of the deal.
At the final offer price, Polyphor is valued at Sfr420m. It began trading on the SIX Swiss Exchange on Tuesday May 15. The final size of the all primary IPO was Sfr165m, including the greenshoe.The stock opened at Sfr40 but ...
Please take a trial or subscribe to access this content.
Contact our subscriptions team to discuss your access: email@example.com